Exhaled Breath Analysis for Detection of Interstitial Lung Diseases Using Real-Time PTR-TOF-MS
Authors:
- Malika MustafinaMMMalika Mustafina
- Aleksandr SuvorovASAleksandr Suvorov
- Maria VergunMVMaria Vergun
- Artemiy SilantyevASArtemiy Silantyev
- Alexander ChernyakACAlexander Chernyak
- Olga SuvorovaOSOlga Suvorova
- Anna ShmidtASAnna Shmidt
- Aida GadzhiakhmedovaAGAida Gadzhiakhmedova
- Daria GognievaDGDaria Gognieva
- Natalia TrushenkoNTNatalia Trushenko
- Galina NekludovaGNGalina Nekludova
- Zamira MerzhoevaZMZamira Merzhoeva
Open Access
- 23 September 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8470
Abstract
Interstitial lung diseases (ILDs) comprise a heterogeneous group of diffuse parenchymal lung disorders requiring accurate non-invasive diagnostic approaches. This study evaluated real-time proton-transfer-reaction time-of-flight mass spectrometry (PTR-TOF-MS) combined with machine learning for breath-based ILD detection and characterization. Overall, 251 patients with ILD and 251 healthy controls underwent analysis of volatile organic compounds (VOCs) during normal quiet breathing and forced expiration. The ILD cohort comprised multiple clinically heterogeneous ILD subtypes. Gradient boosting models were evaluated using repeated Monte Carlo cross-validation, with additional age- and sex-matched validation, ILD subtype classification, and kernel canonical correlation analysis (KCCA). Models incorporating VOCs and demographic variables achieved AUCs of 0.900 and 0.897 for normal and forced breathing, respectively, while VOC-only models retained good discrimination (AUC 0.874 and 0.875). Four VOC-related ions (m/z 55.03859, 63.01996, 90.95284, and 107.0886) were reproducibly identified. Discrimination among individual ILD subtypes was modest, with the highest AUC observed for IPF (0.709). KCCA demonstrated significant associations between VOC signatures and clinical-functional impairment under both breathing conditions. These findings support PTR-TOF-MS breath analysis as a promising non-invasive approach for ILD detection, while subtype classification and disease severity assessment require further independent validation.Keywords
Funding Information
- Russian Science Foundation (24-15-00549)
- the government assignment (1023022600020-6)
This publication has 44 references indexed in Scilit:
- A baseline study of interpretable machine learning using GC-MS breath VOCs for classifying asthma, bronchiectasis, and COPDScientific Reports, 2025
- Diagnosis of Lung Cancer Through Exhaled Breath: A Comprehensive StudyMolecular Diagnosis & Therapy, 2024
- Immune mechanisms in fibrotic interstitial lung diseaseCell, 2024
- Interstitial Lung DiseaseJAMA, 2024
- Exhaled breath analysis in adult patients with cystic fibrosis by real-time proton mass spectrometryClinica Chimica Acta, 2024
- Interstitial lung diseasesThe Lancet, 2022
- Diagnostic Performance of Electronic Nose Technology in SarcoidosisChest, 2021
- A novel lung alveolar cell model for exploring volatile biomarkers of particle-induced lung injuryScientific Reports, 2020
- Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy SubjectsLung, 2017
- Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosisFree Radical Biology and Medicine, 2010